Detalhe da pesquisa
1.
Monoclonal antibodies against GFRα3 are efficacious against evoked hyperalgesic and allodynic responses in mouse join pain models but, one of these, REGN5069, was not effective against pain in a randomized, placebo-controlled clinical trial in patients with osteoarthritis pain.
Neurobiol Pain
; 14: 100136, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38099276
2.
ERBB3/HER2 signaling promotes resistance to EGFR blockade in head and neck and colorectal cancer models.
Mol Cancer Ther
; 13(5): 1345-55, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24634416